Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
PUT
Johnson Controls International
JCI
$86.6B
| $17.6M | 0.02% |
+500,000
| New | +$19M |
|
|
LFC
952
DELISTED
China Life Insurance Company Ltd.
LFC
| $17.6M | 0.02% |
1,258,973
+178,245
| +16% | +$2.74M |
|
953
ICF International
ICFI
$1.59B
| $17.6M | 0.02% |
300,764
+15,038
| +5% | +$848K |
|
954
Take-Two Interactive
TTWO
$43.7B
| $17.6M | 0.02% |
179,686
-110,310
| -38% | -$12.4M |
|
955
Flowers Foods
FLO
$1.54B
| $17.5M | 0.02% |
802,137
+695,979
| +656% | +$14.1M |
|
|
PRAH
956
DELISTED
PRA Health Sciences, Inc.
PRAH
| $17.5M | 0.02% |
210,936
-559,234
| -73% | -$49.7M |
|
957
PRA Group
PRAA
$759M
| $17.4M | 0.02% |
458,613
+150,243
| +49% | +$5.48M |
|
958
STAG Industrial
STAG
$7.14B
| $17.4M | 0.02% |
728,131
-577,540
| -44% | -$14.1M |
|
|
PARA
959
DELISTED
Paramount Global Class B
PARA
| $17.4M | 0.02% |
338,181
+294,590
| +676% | +$16.2M |
|
|
ACOR
960
DELISTED
Acorda Therapeutics
ACOR
| $17.4M | 0.02% |
6,123
+4,466
| +270% | +$13.4M |
|
|
BKI
961
DELISTED
Black Knight, Inc. Common Stock
BKI
| $17.4M | 0.02% |
368,704
-252,941
| -41% | -$12.3M |
|
962
Paylocity
PCTY
$8.09B
| $17.4M | 0.02% |
338,919
-29,401
| -8% | -$1.46M |
|
963
National Bank Holdings
NBHC
$1.86B
| $17.4M | 0.02% |
522,049
+64,138
| +14% | +$2.13M |
|
964
JetBlue
JBLU
$1.87B
| $17.3M | 0.02% |
852,881
-402,282
| -32% | -$8.55M |
|
965
Trip.com Group
TCOM
$29B
| $17.3M | 0.02% |
371,624
-349,682
| -48% | -$16.4M |
|
|
CQH
966
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
| $17.3M | 0.02% |
627,072
+194,945
| +45% | +$5.49M |
|
967
West Pharmaceutical
WST
$24.9B
| $17.2M | 0.02% |
194,693
+152,508
| +362% | +$14.3M |
|
|
IMGN
968
DELISTED
Immunogen Inc
IMGN
| $17.2M | 0.02% |
1,630,982
-1,310,505
| -45% | -$12.9M |
|
|
LHO
969
DELISTED
LaSalle Hotel Properties
LHO
| $17.1M | 0.02% |
591,170
+566,775
| +2,323% | +$15.6M |
|
970
First Bancorp
FBP
$4.31B
| $17.1M | 0.02% |
2,845,990
+1,754,333
| +161% | +$10.3M |
|
971
Alamos Gold
AGI
$16B
| $17.1M | 0.02% |
3,285,644
+1,414,679
| +76% | +$7.94M |
|
972
Canadian Solar
CSIQ
$972M
| $17.1M | 0.02% |
1,050,340
-91,045
| -8% | -$1.47M |
|
973
RELX
RELX
$63.4B
| $17.1M | 0.02% |
817,925
+642,369
| +366% | +$13.9M |
|
974
WaFd
WAFD
$2.69B
| $17.1M | 0.02% |
493,768
+106,842
| +28% | +$3.79M |
|
975
Nutanix
NTNX
$18B
| $17.1M | 0.02% |
347,710
-288,547
| -45% | -$11.4M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.